Celsion Corporation to Participate in Two Investor Conferences in May 2019
Company to Discuss its Ongoing Pivotal Phase III Study in Primary Liver Cancer and its Phase I/II Clinical Study in Ovarian Cancer
The ThinkEquity Conferenceon Thursday, May 2, 2019at The Mandarin Oriental Hotelin New York City.
Deutsche Bank44th Annual Health Care Conferenceon Tuesday, May 7, 2019and Wednesday, May 8, 2019at The InterContinental Hotelin Boston.
A webcast of Celsion’s presentation at the
About Celsion Corporation
ThermoDox® is a registered trademark of
Celsion Investor Contact
Executive Vice President & CFO
Source: Celsion CORP